Table 1.
Baseline characteristics.
| Total | Successful eradication | Failed eradication | |
|---|---|---|---|
| |
|
|
|
| Patient characteristics | |||
| Age | 68 (34–84) | 69 (34–84) | 67 (44–79) |
| Sex (M/F) | 26/21 | 20/16 | 6/5 |
| BMI | 28.9 (20.5–52.0) | 27.9 (20.5–35.1) | 31.5 (20.9–52.0) |
| ASA score 1/2/3/4 | 8/30/8/1 | 6/27/3/0 | 2/3/5/1 |
| Previous infection treatment | 27 | 21 | 6 |
| Time after primary arthroplasty (months) | 64 (3–243) | 57 (4–200) | 86 (3–243) |
| Re-revision |
9 |
7 |
2 |
| Risk factors | |||
| Diabetes mellitus | 7 | 5 | 2 |
| Cardiovascular disease | 22 | 16 | 6 |
| Smoking | 8 | 3 | 5 |
| Alcohol abuse |
7 |
4 |
3 |
| Infection characteristics | |||
| Treatment location | |||
| Hip | 31 | 22 | 9 |
| Knee |
16 |
14 |
2 |
| Zimmerli infection type | |||
| months | 0 | 0 | 0 |
| 3–24 months | 13 | 11 | 2 |
|
months |
34 |
25 |
9 |
| Soft tissue involvement | |||
| Abscess or fistula | 19 | 14 | 5 |
M/F: male/female; body mass index; American Society of Anesthesiologists.